A report on the biologics manufacturing market size is available for the period of 2026-2033. The market is expected to experience growth, driven by factors such as biologics outsourcing and specialized manufacturing, with related markets like contract manufacturing and downstream processing also seeing increases. Specific segments, including veterinary contract manufacturing, biologics CDMO, and others like oligonucleotide therapeutics and exosome-based therapeutics, are also being reported on.